Compare NetEase Inc (NTES) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NetEase Inc vs Summit Therapeutics Inc — how do they compare? NetEase Inc trades at $134.95 (market cap $86.14B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: NetEase Inc is far larger — about 8.2× Summit Therapeutics Inc's market cap, and NetEase Inc pays a 2.25% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| NTES | SMMT | |
|---|---|---|
Market Cap | $86.14B | $10.48B |
Sector | Media | Health |
52-Week High | $159.34 | $29.32 |
52-Week Low | $109.26 | $13.05 |
Enterprise Value | $62.61B | $9.90B |
Dividend Yield | 2.25% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
